Edesa Market Capitalization vs Invested Capital Analysis
EDSA Stock | USD 4.31 0.16 3.58% |
Edesa Biotech financial indicator trend analysis is much more than just examining Edesa Biotech latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Edesa Biotech is a good investment. Please check the relationship between Edesa Biotech Market Cap and its Invested Capital accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Edesa Biotech. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state. For information on how to trade Edesa Stock refer to our How to Trade Edesa Stock guide.
Market Cap vs Invested Capital
Market Capitalization vs Invested Capital Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Edesa Biotech Market Capitalization account and Invested Capital. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between Edesa Biotech's Market Capitalization and Invested Capital is -0.25. Overlapping area represents the amount of variation of Market Capitalization that can explain the historical movement of Invested Capital in the same time period over historical financial statements of Edesa Biotech, assuming nothing else is changed. The correlation between historical values of Edesa Biotech's Market Capitalization and Invested Capital is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Market Capitalization of Edesa Biotech are associated (or correlated) with its Invested Capital. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Invested Capital has no effect on the direction of Market Capitalization i.e., Edesa Biotech's Market Capitalization and Invested Capital go up and down completely randomly.
Correlation Coefficient | -0.25 |
Relationship Direction | Negative |
Relationship Strength | Insignificant |
Market Cap
Invested Capital
Invested capital represents the total cash investment that shareholders and debt holders have contributed to Edesa Biotech. There are two different methods for calculating Edesa Biotech invested capital: operating approach and financing approach. Understanding Edesa Biotech invested capital allows investors to calculate measures of performance such as return on invested capital or return on capital employed.Most indicators from Edesa Biotech's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Edesa Biotech current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Edesa Biotech. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state. For information on how to trade Edesa Stock refer to our How to Trade Edesa Stock guide.At present, Edesa Biotech's Issuance Of Capital Stock is projected to increase significantly based on the last few years of reporting. The current year's Enterprise Value is expected to grow to about 872 M, whereas Selling General Administrative is forecasted to decline to about 3.6 M.
2021 | 2022 | 2023 | 2024 (projected) | Cost Of Revenue | 118.2K | 183.5K | 165.1K | 156.9K | Research Development | 13.3M | 4.8M | 5.5M | 4.3M |
Edesa Biotech fundamental ratios Correlations
Click cells to compare fundamentals
Edesa Biotech Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Edesa Biotech fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 10.8M | 14.6M | 11.6M | 8.9M | 10.2M | 8.7M | |
Other Current Liab | 1.5M | 1.4M | 2.1M | 1.7M | 2.0M | 1.2M | |
Total Current Liabilities | 1.5M | 1.5M | 2.1M | 1.8M | 2.1M | 1.3M | |
Total Stockholder Equity | 6.6M | 13.1M | 9.4M | 7.0M | 8.1M | 6.4M | |
Net Debt | (7.0M) | (7.7M) | (7.1M) | (5.3M) | (4.7M) | (5.0M) | |
Retained Earnings | (13.1M) | (26.5M) | (44.0M) | (52.4M) | (47.2M) | (44.8M) | |
Cash | 7.2M | 7.8M | 7.1M | 5.4M | 6.2M | 5.6M | |
Non Current Assets Total | 2.7M | 2.5M | 2.5M | 2.5M | 2.8M | 3.0M | |
Cash And Short Term Investments | 7.2M | 7.8M | 7.1M | 5.4M | 6.2M | 6.8M | |
Common Stock Shares Outstanding | 8.6M | 12.1M | 16.7M | 20.0M | 23.0M | 24.2M | |
Liabilities And Stockholders Equity | 10.8M | 14.6M | 11.6M | 8.9M | 10.2M | 8.7M | |
Other Current Assets | 890.3K | 948.6K | 2.0M | 448.9K | 516.2K | 429.9K | |
Other Stockholder Equity | 1.3M | 4.7M | 11.2M | 13.0M | 15.0M | 15.7M | |
Total Liab | 4.1M | 1.5M | 2.2M | 1.8M | 2.1M | 2.3M | |
Total Current Assets | 8.1M | 12.1M | 9.1M | 6.4M | 7.4M | 7.6M | |
Property Plant And Equipment Net | 174.8K | 111.6K | 31.2K | 100.1K | 90.1K | 85.6K | |
Net Receivables | 87.4K | 3.3M | 1.3M | 626.5K | 720.5K | 521.2K | |
Property Plant And Equipment Gross | 174.8K | 145.4K | 70.7K | 143.9K | 129.5K | 123.1K | |
Accumulated Other Comprehensive Income | (287.2K) | (205.3K) | (213.6K) | (214.6K) | (193.2K) | (202.8K) | |
Non Current Liabilities Total | 2.6M | 67.7K | 43.7K | 19.8K | 17.8K | 16.9K | |
Inventory | 224.3K | (217.1K) | (87.4K) | (1.3M) | (1.1M) | (1.1M) | |
Common Stock | 18.5M | 34.9M | 42.5M | 46.6M | 53.6M | 39.4M | |
Property Plant Equipment | 73.1K | 174.8K | 111.6K | 31.2K | 28.0K | 26.6K | |
Net Tangible Assets | 5.3M | 4.1M | 10.7M | 7.1M | 8.2M | 4.3M | |
Accounts Payable | 1.5M | 1.4M | 2.1M | 1.7K | 2.0K | 1.9K | |
Net Invested Capital | 6.6M | 13.1M | 9.4M | 7.0M | 8.1M | 9.4M | |
Net Working Capital | 6.6M | 10.6M | 7.0M | 4.6M | 4.2M | 5.8M | |
Capital Stock | 18.5M | 34.9M | 42.5M | 46.6M | 53.6M | 38.7M |
Pair Trading with Edesa Biotech
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Edesa Biotech position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Edesa Biotech will appreciate offsetting losses from the drop in the long position's value.Moving against Edesa Stock
0.55 | ELEV | Elevation Oncology Earnings Call Next Week | PairCorr |
0.45 | VKTX | Viking Therapeutics Potential Growth | PairCorr |
The ability to find closely correlated positions to Edesa Biotech could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Edesa Biotech when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Edesa Biotech - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Edesa Biotech to buy it.
The correlation of Edesa Biotech is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Edesa Biotech moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Edesa Biotech moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Edesa Biotech can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Edesa Biotech. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state. For information on how to trade Edesa Stock refer to our How to Trade Edesa Stock guide.You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Complementary Tools for Edesa Stock analysis
When running Edesa Biotech's price analysis, check to measure Edesa Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Edesa Biotech is operating at the current time. Most of Edesa Biotech's value examination focuses on studying past and present price action to predict the probability of Edesa Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Edesa Biotech's price. Additionally, you may evaluate how the addition of Edesa Biotech to your portfolios can decrease your overall portfolio volatility.
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
CEOs Directory Screen CEOs from public companies around the world | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |
Is Edesa Biotech's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Edesa Biotech. If investors know Edesa will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Edesa Biotech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (20.16) | Quarterly Revenue Growth (1.00) | Return On Assets (0.56) | Return On Equity (0.96) |
The market value of Edesa Biotech is measured differently than its book value, which is the value of Edesa that is recorded on the company's balance sheet. Investors also form their own opinion of Edesa Biotech's value that differs from its market value or its book value, called intrinsic value, which is Edesa Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Edesa Biotech's market value can be influenced by many factors that don't directly affect Edesa Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Edesa Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Edesa Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Edesa Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.